Viola Partners
12 Abba Eban Avenue, Ackerstein Towers Building D, Herzliya Pituach, 4672530, Israel
Overview
Founded in 2000 under the name of D Partners, Viola Partners currently has three funds under management and managed SPVs, aggregating approximately US$350 million in capital commitments, from leading international and Israeli private investors. Viola Partners is a unique investment fund created to accommodate the General Partners and other private investors, who wish to receive priority access to, and invest in and with the Viola Group, in a uniquely tailored model.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Business Development
- Finance
- Venture Capital
Investment portfolio
- AngioSlide
Participated · Series C · Jan 2013
Angioslide develops the PROTEUS Embolic Capture Angioplasty solution, a combined PTA balloon and embolic capture-and-removal device. PROTEUS has received FDA clearance and European CE Mark approval for lower limb use. The company intends to use new capital to expand in the USA, improve its product offering and validate the technology in additional vascular beds. Angioslide is privately held, was founded in 2005, and is led by CEO Lihu Avitov. It maintains regional offices in Europe and the US. The company raised $6.3M in a Series C to support these plans.
Team
No current team members are available.